SURGE Therapeutics Funding: $58M Raised, Series B (2023)
SURGE Therapeutics is a Biotech company based in Cambridge, MA. It has raised $58M in total funding. Latest round: Series B.
SURGE Therapeutics funding overview
SURGE Therapeutics is a Biotech company based in Cambridge, MA. SURGE Therapeutics has raised $58M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in July 2023. The round record for SURGE Therapeutics runs through 2023; nothing later has been disclosed. Investors on record include Camford Capital, Khosla Ventures, Intuitive Ventures, Cancer Research Institute, 8VC, Alumni Ventures and 2 others. 8 distinct backers are named across the disclosed rounds.
SURGE Therapeutics at a glance
Total raised
$58M
Latest round
Series B
Latest round date
July 2023
Industry
Biotech
Headquarters
Cambridge, MA
Notable investors
Camford Capital, Khosla Ventures, Intuitive Ventures, Cancer Research Institute, 8VC, Alumni Ventures, Pitango HealthTech, Bioluminescence Ventures
Frequently asked about SURGE Therapeutics funding
How much has SURGE Therapeutics raised?
SURGE Therapeutics has raised $58M in total disclosed funding across the rounds on record.
Who has invested in SURGE Therapeutics?
Camford Capital, Khosla Ventures, Intuitive Ventures, Cancer Research Institute, 8VC, Alumni Ventures are named among the investors backing SURGE Therapeutics.
What was the latest SURGE Therapeutics funding round?
The most recent disclosed round is a Series B, announced in July 2023.
Where is SURGE Therapeutics based?
SURGE Therapeutics is based in Cambridge, MA.
What sector does SURGE Therapeutics operate in?
SURGE Therapeutics is tracked under Biotech from Cambridge, MA, with $58M in disclosed funding.
When did SURGE Therapeutics last raise?
The last disclosed SURGE Therapeutics round closed in July 2023 at Series B.
Round data for SURGE Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in Cambridge and backer lists below.
